176 related articles for article (PubMed ID: 9450621)
1. The effects of levosimendan on [Ca2+]i in guinea-pig isolated ventricular myocytes.
Lancaster MK; Cook SJ
Eur J Pharmacol; 1997 Nov; 339(1):97-100. PubMed ID: 9450621
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
[TBL] [Abstract][Full Text] [Related]
3. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
Sato S; Talukder MA; Sugawara H; Sawada H; Endoh M
J Mol Cell Cardiol; 1998 Jun; 30(6):1115-28. PubMed ID: 9689586
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
5. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
6. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
Bódi A; Szilágyi S; Edes I; Papp Z
Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
[TBL] [Abstract][Full Text] [Related]
7. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
8. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts.
Kristof E; Szigeti G; Papp Z; Bodi A; Ball NA; Walsh RA; Edes I
Basic Res Cardiol; 1999 Aug; 94(4):223-30. PubMed ID: 10505421
[TBL] [Abstract][Full Text] [Related]
9. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.
Szilágyi S; Pollesello P; Levijoki J; Kaheinen P; Haikala H; Edes I; Papp Z
Eur J Pharmacol; 2004 Feb; 486(1):67-74. PubMed ID: 14751410
[TBL] [Abstract][Full Text] [Related]
10. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
11. Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer.
Virág L; Hála O; Marton A; Varró A; Papp JG
Gen Pharmacol; 1996 Apr; 27(3):551-6. PubMed ID: 8723543
[TBL] [Abstract][Full Text] [Related]
12. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
[TBL] [Abstract][Full Text] [Related]
13. Cardiotonic drugs differentially alter cytosolic [Ca2+] to left ventricular relationships before and after ischemia in isolated guinea pig hearts.
Chen Q; Camara AK; Rhodes SS; Riess ML; Novalija E; Stowe DF
Cardiovasc Res; 2003 Oct; 59(4):912-25. PubMed ID: 14553831
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Kaheinen P; Pollesello P; Levijoki J; Haikala H
J Cardiovasc Pharmacol; 2004 Apr; 43(4):555-61. PubMed ID: 15085067
[TBL] [Abstract][Full Text] [Related]
15. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
[TBL] [Abstract][Full Text] [Related]
16. Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart.
Feridooni HA; MacDonald JK; Ghimire A; Pyle WG; Howlett SE
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H46-H59. PubMed ID: 27793852
[TBL] [Abstract][Full Text] [Related]
17. A Review on Role of the Calcium Sensitive Inotropic Agent, Levosimendan and Its Metabolites.
Asif M
Mini Rev Med Chem; 2018; 18(16):1354-1362. PubMed ID: 27594341
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
19. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.
Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H
Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868
[TBL] [Abstract][Full Text] [Related]
20. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium.
Lochner A; Colesky F; Genade S
Cardiovasc Drugs Ther; 2000 Jun; 14(3):271-81. PubMed ID: 10935149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
